First Time Loading...

Sanofi SA
NASDAQ:SNY

Watchlist Manager
Sanofi SA Logo
Sanofi SA
NASDAQ:SNY
Watchlist
Price: 49.01 USD -0.91% Market Closed
Updated: May 5, 2024

Wall Street
Price Targets

SNY Price Targets Summary
Sanofi SA

Wall Street analysts forecast SNY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SNY is 57.47 USD with a low forecast of 42.74 USD and a high forecast of 69.42 USD.

Lowest
Price Target
42.74 USD
13% Downside
Average
Price Target
57.47 USD
17% Upside
Highest
Price Target
69.42 USD
42% Upside

SNY Last Price Targets
Sanofi SA

The latest public price target was made on Apr 3, 2024 by Jasper Hellweg from Argus Research , who expects SNY stock to rise by 12% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Jasper Hellweg
Argus Research
55 USD
Upside 12%
1 month ago
Apr 3, 2024
Sanofi-Aventis (SNY) PT Lowered to $55 at Argus, 'BUY as FDA reviews Dupixent for COPD'
StreetInsider
Jasper Hellweg
Argus Research
Price Target 55 USD
Upside/Downside 12%
View Source
Sanofi SA Competitors:
Price Targets
MARKSANS
Marksans Pharma Ltd
81% Downside
4151
Kyowa Kirin Co Ltd
17% Upside
ROVI
Laboratorios Farmaceuticos ROVI SA
3% Upside
688356
Jenkem Technology Co Ltd
40% Upside
APLLTD
Alembic Pharmaceuticals Ltd
14% Downside
DPHARMA
Duopharma Biotech Bhd
23% Upside
SUNPHARMA
Sun Pharmaceutical Industries Ltd
2% Upside
128940
Hanmi Pharm Co Ltd
33% Upside

Revenue
Forecast

Revenue Estimate
Sanofi SA

For the last 8 years the compound annual growth rate for Sanofi SA's revenue is 4%. The projected CAGR for the next 3 years is 5%.

4%
Past Growth
5%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Sanofi SA

For the last 8 years the compound annual growth rate for Sanofi SA's operating income is 5%. The projected CAGR for the next 3 years is 11%.

5%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-23%
Average Miss

Net Income
Forecast

Net Income Estimate
Sanofi SA

For the last 8 years the compound annual growth rate for Sanofi SA's net income is 3%. The projected CAGR for the next 3 years is 30%.

3%
Past Growth
30%
Estimated Growth
Estimates Accuracy
-33%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SNY's stock price target?
Price Target
57.47 USD

According to Wall Street analysts, the average 1-year price target for SNY is 57.47 USD with a low forecast of 42.74 USD and a high forecast of 69.42 USD.

What is Sanofi SA's Revenue forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for Sanofi SA's revenue is 4%. The projected CAGR for the next 3 years is 5%.

What is Sanofi SA's Operating Income forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Sanofi SA's operating income is 5%. The projected CAGR for the next 3 years is 11%.

What is Sanofi SA's Net Income forecast?
Projected CAGR
30%

For the last 8 years the compound annual growth rate for Sanofi SA's net income is 3%. The projected CAGR for the next 3 years is 30%.